Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing…
Ferrer’s Progressive Supranuclear Palsy (PSP) License Agreement with Asceneuron
